Abstract
Chiral Lewis base (LB) organocatalysis has emerged as a powerful covalent catalysis concept which allows for highly selective asymmetric C–C and C-heteroatom bond formations. Considering significant recent progress in the development of strategies to access α-heterofunctionalized carboxylic acid derivatives under chiral LB catalysis, we wish to summarize the most significant concepts and advances in this field within this mini review now.
Keywords: Organocatalysis, Covalent catalysis, Lewis bases, Heterofunctionalizations, Carboxylic acid derivatives
1. Introduction
Chiral Lewis base (LB) organocatalysis has emerged as a powerful concept within the realm of asymmetric catalysis [1–7]. Upon in situ addition of a LB to electron deficient Lewis acidic groups of starting materials and reagents (most commonly via n(LB) -> π*(reagent) interactions) activated chiral intermediates are obtained, which then allow for unique transformations with often excellent levels of stereo-control. Different classes of Lewis bases have been successfully established for the activation and control of various starting materials and reaction partners [1–7], thus resulting in a broad and generally applicable catalysis concept that has been carefully reviewed in numerous excellent overview articles over the last two decades [2–4,7]. Amongst the different classes of compounds that can be successfully engaged in asymmetric LB-catalyzed transformations, carbonyl compounds and carboxylic acid derivatives turned out to be especially rewarding, allowing for the use of easily accessible starting materials for highly appealing transformations. The utilization of aldehydes and ketones in combination with chiral LBs most usually proceeds via iminium and enamine intermediates (when using 1° or 2° amines) [8] or Breslow type intermediates (using N-heterocyclic carbenes (NHCs) [9]. On the other hand, the use of activated carboxylic acid derivatives (i), ketenes (ii), carbaldehydes with a leaving group in the α-position (iii), or carbaldehydes under oxidative conditions (iv) in combination with LBs such as 3° amines, pyridine derivatives, isothioureas (ITU), or NHCs proceeds via the formation of so-called C1-LB enolates (Scheme 1) [2–4]. These species benefit from their high nucleophilicity and a well-defined enolate geometry, thus combining high reactivity with usually high levels of stereocontrol for α-functionalization reactions. Following the stereo-defining addition to an electrophilic species, the covalently bound LB can be released upon addition of either an (external) nucleophile in a bimolecular reaction or via an intramolecular cyclization path (in case a dipolar reaction partner has been utilized). In general, the field of C1-LB enolate chemistry i.e. when using 3° amine catalysts or pyridine-based catalysts (giving C1 ammonium enolates) has a long-standing history dating back to Pracejus’ seminal report describing the Cinchona alkaloid-catalyzed asymmetric methanolysis of ketenes proceeding via an in situ formed C1 enolate [10]. While initially these C1 enolates have primarily been engaged in C–C bond forming reactions or ketene solvolysis approaches [2], it was also soon realized that such species serve well for asymmetric α-heterofunctionalization reactions [11,12]. Considering significant progress in the development of asymmetric approaches to access valuable α-heterofunctionalized carboxylic acid derivatives under chiral LB catalysis, we herein wish to summarize the most significant concepts and advances in this field. Our main focus hereby lies on strategies where the catalytically generated chiral C1-LB enolate is engaged in an asymmetric Cα-heteroatom bond formation, while approaches relying on e.g. asymmetric protonations of C1 ammonium enolates [13], resolutions of racemic α-heterofunctionalized compounds [14], asymmetric C–C-bond forming reactions of prochiral α-heterofunctionalized derivatives [15], or asymmetric [2, 3]-rearrangements [16] are not within the scope of this mini-review.
Scheme 1. In situ generation and subsequent utilization of chiral C1-LB enolates.
2. α-Halogenations
Asymmetric α-halogenations [17] have clearly been the most thoroughly investigated and furthest developed α-heterofunctionalization reactions of in situ generated chiral C1-LB enolates. The value of the hereby obtained α-halogenated carboxylic acid derivatives can on the one hand be attributed to potentially interesting biological properties associated either with these carboxylic acid derivatives themselves, or with more complex halogenated structures accessed therefrom (this comes especially true for fluorinated derivatives) [17]. On the other hand, chiral α-chlorinated or α-brominated carboxylic acid derivatives serve well for further stereospecific SN2 displacements with various nucleophiles, thus representing valuable chiral building blocks for the synthesis of compounds where the direct asymmetric installation of the target group is problematic.
Pioneering early contributions on asymmetric α-halogenations of C1-LB enolates were reported by Lectka’s group around two decades ago (Scheme 2) [12]. Upon utilizing acyl halides 1 as pronucleophiles and cyclohexadienone 2 as an electrophilic Cl-transfer reagent in the presence of Cinchona alkaloids (e.g. QN1) as chiral Lewis base catalysts and an external Brønsted base they managed to access the α-chlorinated aryl esters 3 with high yields and excellent levels of enantioselectivities. Mechanistically, this transformation proceeds via in situ ketene formation which, upon LB-addition, gives the crucial chiral C1 enolate which then adds to reagent 2 first, followed by “back-biting” and replacement of the LB by the in situ generated phenolate species. This conceptually impressive approach where the carefully chosen electrophilic chlorine transfer reagent is not only relevant for the α-Cl-installation but also forms a nucleophilic species (a phenolate) in situ represents a remarkable development for the whole field as it allows for efficient catalyst turnover. Furthermore, the hereby accessed activated aryl esters 3 were successfully utilized for further manipulations like direct amide-bond formations, which underscores the synthetic versatility of these products. Interestingly, the nature of the external base was found to be crucial in order to allow for efficient ketene-formation and to suppress by-product formation and non-productive pathways like e.g. ketene hydrolysis. In their initial studies, Lectka’s team used a solid-supported phosphazene base (BEMP resin). Later studies however showed that other bases (e.g. NaH/crown ether combinations) and modified Cl-transfer reagents can be successfully utilized as well [18]. These pioneering developments, which were also accompanied by very helpful mechanistic studies, set the stage for a variety of further developments in the field of C1-LB enolate chemistry and, in addition to these α-chlorinations, analogous α-brominations were successfully developed as well. Hereby electrophilic Br-transfer reagents like compound 4 were found to be well-suited, being again capable of forming the crucial phenolate species that allows for catalyst turnover in situ [12,18].
Scheme 2. Lectka’s pioneering Cinchona alkaloid-catalyzed α-halogenation reports of in situ formed ketenes.
A few years after Lectka’s seminal reports utilizing halides 1 as α-substituted ketene precursors (Scheme 2), Fu’s group reported the direct utilization of α,α-disubstituted ketenes 6 for α-chlorinations with ketone 7 in the presence of their planar chiral pyridine-based LB catalyst PPY (Scheme 3, upper reaction) [19a]. Remarkably, this approach gives access to tetrasubstituted chlorinated stereocenters with high levels of enantioselectivities upon using low amounts of catalyst PPY only and further manipulations of the ester functionality can easily be carried out as well. Shortly after, Smith’s group utilized in situ generated NHCs (e.g. starting from pre-NHC1) as LB catalysts for analogous reactions, in this case however relying on Cl-reagent 2 (Scheme 3) [19b] and some years later chloral was also successfully used as an alternative Cl-transfer re-agent for such reactions [19c].
Scheme 3. Lewis base-catalyzed α-halogenations of α,α-disubstituted ketenes 6.
A few years after introducing their α-chlorination and α-bromination strategies via in situ formed ketenes (Scheme 2), Lectka’s group also reported analogous α-fluorination reactions (Scheme 4, upper part) [20]. However, some important changes and optimizations as compared to their Cl/Br-transfer protocols were necessary. First of all, the concept of using electrophilic halogen-transfer reagents which form the required nucleophilic species that allow for catalyst turnover in situ is not feasible hereby, as established F+-reagents (like NFSI) usually only form weakly nucleophilic species after the F-transfer. Thus, reaction conditions employing external nucleophiles (like alcohols or amines) had to be established. In addition, it was found that the addition of Pd-complexes like (PPh3)2PdCl2 has a very positive effect on the overall performance resulting in significantly enhanced yields. This can be explained by formation of a highly reactive dually activated C1 enolate. In detailed and mechanistically driven follow-up studies it was even shown that the addition of Li additives leads to further activation by increasing the reactivity of the NFSI, thus resulting in an impressive triple-activation strategy [20].
Scheme 4. Asymmetric α-fluorination approaches of in situ (Lectka) or preformed (Fu) ketenes.
Using preformed ketenes 6 again, Fu’s group was able to successfully extend their PPY-catalyzed chlorination strategy (Scheme 3) to α-fluorinations next (Scheme 4, lower part) [21]. Hereby, catalyst turnover was successfully achieved by using C6F5ONa as an external nucleophile, which gives access to the α-fluoro esters 12 with excellent enantiose-lectivities and further ester manipulations were successfully reported again.
Besides the already mentioned Cinchona alkaloids, pyridine-based-catalysts, and NHCs, also isothioureas (ITUs) have, over the course of the last years, been very successfully used for asymmetric C1-LB enolate chemistry [3]. These catalysts are most commonly employed in combination with activated carboxylic acid derivatives (either preformed or in situ formed) which, in the presence of an external base, gives the geometrically well-defined chiral C1-ITU enolate in situ [3]. Surprisingly however, the potential of these catalysts to facilitate asymmetric α-halogenations has only recently been established [22,23]. In 2021, Zheng’s group introduced the para-cyclophane-based ITU pcpITU which was successfully used for the α-fluorination of free carboxylic acids 12 (Scheme 5) [22a]. Hereby, acid 12 is in situ activated by using TsCl to form the mixed anhydride. This species then reacts with the LB and upon deprotonation gives the chiral C1 enolate which adds to NFSI. Catalyst turnover was hereby achieved by addition of alcohols, thus giving access to the α-fluorinated esters 13 containing a tri-substituted stereogenic center. Furthermore, this in situ acid-activation – fluorination strategy could successfully be expanded to alkyne-based acids 14, which allow for the synthesis of α-F-esters 15 with a tetrasubstituted stereogenic center [22b]. Hereby, the authors relied on BTM as a readily available ITU derivative instead and isopropanol was found to be the alcohol of choice allowing for good yields and catalyst turnover.
Scheme 5. Isothiourea-catalyzed α-fluorination of in situ activated carboxylic acid derivatives.
More or less in parallel to Zheng’s contributions, our group focused on ITU-catalyzed α-chlorination reactions using NCS as an easily available electrophilic Cl-transfer reagent (Scheme 6) [23]. Instead of starting from free carboxylic acids 12 or 14 we employed electron deficient aryl esters 16 as starting materials first [23a]. We hereby found it crucial to carry out the BTM-catalyzed reaction of 16 with NCS and the sub-sequent alcohol-quench under cryogenic conditions, to avoid racemization of the intermediate catalyst-bound α-chlorinated species. Employing this strategy, a variety of α-Cl esters 18 could be obtained straightforwardly. Investigating the use of alternative starting materials next, we recently developed a photochemical protocol starting from α-diazoketones 19 [23b]. Under blue LED irradiation these compounds undergo a Wolff rearrangement forming the corresponding ketene. This ketene is then trapped by the ITU followed by subsequent α-chlorination and ROH addition to release the catalyst again (in analogy to the other ketene approaches discussed above already). Hereby we also demonstrated the suitability of products 18 for stereospecific SN2 reactions with heteroatom nucleophiles, which gives access to various α-hetero-functionalized esters with high levels of stereocontrol.
Scheme 6. Isothiourea-catalyzed α-chlorination of activated esters and in situ generated ketenes.
As stated in the introductory part, C1-LB enolates can not only be accessed from ketenes and carboxylic acid derivatives, but also from carbaldehydes. In this case, it is possible to start from carbaldehydes under oxidative conditions, from derivatives that contain a suited leaving group in the α-position or, as impressively shown by Lin and Sun around 10 years ago, by using enals 20 with a leaving group in the γ-position [24a]. Utilizing these starting materials in the presence of the chiral NHC generated from pre-NHC2 allows for the formation of the α-fluorinated β,γ-unsaturated esters 21 with excellent enantioselectivities. Mechanistically, aldehydes 20 and the NHC catalyst first form a conjugated C1–NHC enolate species which then reacts with NFSI in an asymmetric fashion followed by methanolysis to release the catalyst again (Scheme 7, upper transformation). Alternatively, simple carbaldehydes 22 can also be successfully utilized for the syntheses of α-F-esters 11 when using chiral NHCs in the presence of an excess of NFSI [24b,c]. Hereby the NFSI plays a dual role, as it not only serves as the electrophilic F-transfer reagent, but it also oxidizes the initially formed Breslow intermediate giving the required C1-LB enolate, which then reacts further in the established manner (Scheme 7, lower part).
Scheme 7. Chiral NHC-catalyzed fluorinations starting from carbaldehydes.
3. Chalcogenations
Asymmetric α-chalcogenations, i.e. α-oxygenations of prochiral enolate species are important transformations to access valuable chiral building blocks. Surprisingly, despite a lot of recent advancements in the introduction of different catalysis concepts to access enantioenriched α-heterofunctionalized carbonyl compounds [11,25], asymmetric α-chalcogenations of C1-LB enolates have so far been less thoroughly developed. One challenge of such approaches so far is the identification of suited reactive electrophilic chalcogen-transfer reagents that allow for asymmetric induction and either trigger the subsequent catalyst turnover themselves or which do not interfere with other nucleophiles that are required for catalyst turnover (please compare with the different successfully developed catalyst turnover strategies discussed above).
Pioneering contributions were again reported by Lectka’s group, who first described the Cinchona alkaloid-based α-oxygenation of acyl halides 1 with o-benzoquinone 23 in 2006 (Scheme 8) [26a]. This approach proceeds via ketene-formation/C1-LB enolate formation first and subsequent hetero-[4 + 2]-cycloaddition with 23, providing the bicyclic lactones 24 with excellent enantioselectivities. Compounds 24 can then be successfully converted into α-hydroxy esters 25 via a two-step process involving lactone hydrolysis (addition of alcohols) and subsequent oxidative cleavage off the α-phenol ether functionality by using ceric ammonium nitrate (CAN). Remarkably, in follow-up studies [26b] the authors realized for the first time that the addition of Pd(II) compounds allows for significantly increased reaction rates and yields, which was attributed to the formation of the doubly activated C1-LB enolates, a concept that was later on then very successfully utilized for the above discussed LB-catalyzed α-fluorination reactions as well (Scheme 4) [20].
Scheme 8. Chiral Cinchona alkaloid-catalyzed hetero-[4 + 2]-cycloadditions delivering α-oxygenated carboxylic acid derivatives.
In 2009, Fu’s group expanded their chiral pyridine-based ketene-activation strategy (compare with Schemes 3 and 4) to the hetero-[2 + 2]-cycloaddition of ketenes 6 with nitroso compounds 26 (Scheme 9) [27]. This strategy allows for the highly enantioselective synthesis of 1, 2-oxazetidin-3-ones 27 first, which can then be successfully utilized to access α–OH–carboxylic acid derivatives 28 straightforwardly.
Scheme 9. Chiral pyridine-catalyzed synthesis of α-oxygenated carboxylic acid derivatives.
N-sulfonyl oxaziridines like compounds 29 are well-established electrophilic O-transfer reagents which have been successfully used for α-hydroxylation reactions of various pronucleophiles [28]. In 2010, Ye’s group first succeeded in utilizing these versatile reagents for asymmetric formal [3 + 2]-cycloadditions with ketenes 6 under chiral NHC catalysis (Scheme 10, upper reaction) [29]. Remarkably, under carefully optimized conditions they managed to utilize racemic oxaziridines 29 for the synthesis of the cyclic α-oxygenated carboxylic acid derivatives 30 with high levels of diastereo- and enantioselectivities. Simultaneously, an efficient kinetic resolution of the mismatching oxaziridine enantiomer was observed as well. Remarkably, the sense of asymmetric induction was depending on the OR-group of the catalyst and either of the two enantiomers of products 30 could easily be accessed by switching from free OH-containing NHCs to OSiR3-protected derivatives. Furthermore, cyclic compounds 30 could easily be hydrolyzed to the free α-hydroxy carboxylic acids 28 containing a tetra-substituted stereogenic center. Noteworthy, in this contribution Ye and co-workers also demonstrated that analogous tri-substituted targets 31 (with R═H) can be accessed as well by starting from acyl halides 1 in the presence of chiral Cinchona alkaloid catalysts.
Scheme 10. Chiral C1-LB enolate [3 + 2]-cycloadditions with oxaziridines 29.
A few years after, Smith’s group reported the use of symmetric anhydrides 32 for analogous [3 + 2]-cycloadditions (Scheme 10, lower reaction) [30]. Hereby chiral ITUs, i.e. HyperBTM, were successfully used as chiral Lewis base catalysts. Interestingly, these transformations can either be carried out by using 2 equiv. of racemic oxaziridines 29 proceeding with a simultaneous oxaziridine resolution, or by using a stoichiometric amount of enantiopure 29. Very recently, David’s and Schulz’s groups also reported the successful use of immobilized ITUs for such transformations, thus allowing for easy recovery of the chiral catalyst [31].
Surprisingly to us, besides these α-oxygenation reports no further successful enantioselective α-chalcogen approaches of C1-LB enolates have been described so far, at least to the best of our knowledge. Thus, our group recently investigated the potential of LB ammonium enolate chemistry to facilitate asymmetric α-sulfanylation and α-selenation reactions as outlined in Scheme 11. We focused on chiral ITU catalysis in combination with either activated aryl esters 16 or the symmetric anhydrides 32 to carry out α-chalcogenations with different electrophilic S (e)R-transfer reagents. Unfortunately however, despite of an extensive screening of different catalysts and conditions (solvents, nucleophilic quenching reagents, …) we only obtained racemic α-S(e)R-containing esters or carboxylic acids, thus clearly illustrating the limits of the existing methods. A possible alternative strategy to access such targets in an enantioenriched manner is presented in Scheme 6 as we recently found that enantioenriched α-Cl-esters 18 can undergo stereospecific nucleophilic displacement reactions with e.g. S-nucleophiles [23b], which allows for the asymmetric synthesis of targets (like compound 33) that are not yet accessible with direct electrophilic C1-LB enolate α-heterofunctionalization reactions.
Scheme 11. Attempted asymmetric α-sulfanylation and α-selenation reactions.
4. Aminations
The asymmetric catalytic synthesis of α-aminated carbonyl derivatives via electrophilic α-amination reactions of prochiral enolate species is an important task [25]. As for the above-mentioned halogenations and chalcogenations, the successful development of C1-LB enolate-based α-aminations very much requests carefully chosen electrophilic N-transfer reagents and suited strategies for catalyst turnover. Seminal contributions in this field again stem from Lectka’s group [32], who successfully utilized o-benzoquinone imides 34 (and analogous diimides [32a]) for asymmetric [4 + 2]-cycloadditions with acyl halide 1 in 2006 already [32b]. This approach, which again proceeds via in situ ketene formation and subsequent C1-Cinchona enolate formation (compare with Scheme 2), provides a straightforward entry to the chiral 1,4-benzoxazinones 35, which can then undergo ring opening and oxidative N-aryl cleavage towards the α-amino esters 36 (Scheme 12, upper example) [32b]. Subsequent studies also showed that the addition of Lewis acids, like Sc(OTf)3, allows for additional activation of electrophile 34, thus increasing yield and conversion rate [32c].
Scheme 12. Chiral LB-catalyzed [4 + 2]-cycloaddition (Lectka, Ye) and [2 + 2]-cycloaddition (Fu) strategies using ketenes to access α-amino carboxylic acid derivatives.
Shortly after, Fu’s group reported the [2 + 2]-cycloaddition of ketenes 6 with diazodicarboxylates 37 in the presence of chiral pyridine catalysts [33]. Hereby, the azalactames 38 are formed first (Scheme 12, 2nd reaction), which can then be engaged in several follow-up transformations, like the ring opening hydrolysis to α-amino acids or analogous esters 39 and 40. The activation of ketenes 6 can also be achieved by using NHCs, as demonstrated by Ye’s group who showed that the reaction of 6 and acceptor 41 allows for the enantioselective synthesis of the [4 + 2]-cycloaddition products 42 (Scheme 12, lower reaction) [34]. Noteworthy, the sense of induction of this cycloaddition can be steered by using NHC-precursors which possess the same absolute configuration but different substitution patterns [34].
The use of ITUs for asymmetric α-amination reactions was first reported by Smith’s group in 2012 (Scheme 13, upper reaction) [35]. Starting from arylacetic acids 44, which can be in situ activated using benzoylchloride, the reaction with compounds 41 in the presence of chiral ITUs proceeds via a [4 + 2]-cycloaddition delivering the primary reaction product 45 which can directly be hydrolyzed to ester 46 upon addition of MeOH. Noteworthy, the subsequent SmI2-mediated reductive N–N-cleavage of compounds 46 to α-amino esters 47 was successfully demonstrated as well. In follow-up studies, the Smith group also showed that analogous reactions can be carried out with high selectivities by starting from either symmetric anhydrides 32 or β,γ-unsaturated carboxylic acids as well [35].
Scheme 13. ITU-catalyzed α-amination strategies.
Recently, Gong and co-workers introduced a highly enantioselective [3 + 2]-cycloaddition of activated esters 16 and diaziridinone 48 (Scheme 13, lower reaction) [36]. Hereby an elegant cooperative catalysis approach using BTM to activate compound 16 and CuCl to activate 48 was developed, thus providing a very efficient and highly enantioselective catalytic protocol to access hydantoins 49 in a straightforward manner.
As mentioned in the introduction, C1-LB enolates can also be accessed by starting from carbaldehydes containing a leaving group in the α-position (compare with Scheme 1). In 2013, Smith’s group reported the use of α-aroyloxyaldehydes 50 as C1-LB enolate precursors under NHC catalysis, which allowed for asymmetric [4 + 2]-cycloadditions with diazo-compounds 41 (Scheme 14) and subsequent transformations in analogy to the above described ITU process (Scheme 13) [37].
Scheme 14. NHC-catalyzed α-amination of α-aroyloxyaldehydes.
5. Conclusion
Asymmetric C1-Lewis base enolate chemistry has been established as a powerful covalent organocatalysis strategy to access a diverse array of valuable carboxylic acid derivatives in a stereoselective manner. As outlined in this minireview, over the course of the last two decades this concept has been very successfully utilized for various α-heterofunctionalization reactions. Different catalyst classes, i.e. chiral Cinchona alkaloids, N-heterocyclic carbenes, pyridine derivatives, and isothioureas have been used for the activation and control of starting materials like carboxylic acid halides, free carboxylic acids, ketenes, activated esters, or suited carbaldehydes, thus resulting in a multitude of divers and broadly applicable methods. Interestingly, while asymmetric α-halogenations have been investigated very successfully allowing for the introduction of a variety of conceptually different approaches so far, α-chalcogenations and α-pnictogenations have so far less generally been established and are limited to α-oxygenations and α-aminations so far. On the other hand, analogous α-sulfanylations/selenations are yet missing. One aspect that turned out to be crucial herein is the identification of suited electrophilic heteroatom-transfer reagents that show sufficient reactivity and which also allow for high enantioselectivities under these covalent catalysis conditions, as exemplified for our failed attempts to establish enantioselective α-sulfanylations and selenations (Scheme 11). Thus, it has to be emphasized that despite of the recent progress that has been made for α-halogenations, α-oxygenations and α-aminations, this field is still an emerging one, which will require future studies to overcome the existing limitations by introducing new catalyst motives and/or establishing alternative electrophilic heteroatom transfer reagents.
Acknowledgments
Our own research in this field has been generously supported by the Austrian Science Funds (FWF) through project P31784.
Footnotes
CRediT authorship contribution statement
Magdalena Piringer: Writing – original draft. Lotte Stockhammer: Writing – original draft. Lukas Vogl: Writing – original draft. David Weinzierl: Writing – original draft. Paul Zebrowski: Writing – original draft. Mario Waser: Writing – original draft.
Declaration of competing interest
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:
Mario Waser reports financial support was provided by Austrian Science Fund. Mario Waser is member of the editorial adivsory board of the journal. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Data availability
This is a review article. Everything covered herein was cited in the reference section.
References
- [1].For general overviews on Lewis base catalysis:. Denmark SE, Beutner GL. Angew Chem Int Ed. 2008;47:1560–1638. doi: 10.1002/anie.200604943. ; b) Vedejs E, Denmark SE, editors. Lewis Base Catalysis in Organic Synthesis. Wiley-VCH; 2016. [DOI] [PubMed] [Google Scholar]
- [2].a) Gaunt MJ, Johansson CCC. Chem Rev. 2007;107:5596–5605. doi: 10.1021/cr0683764. [DOI] [PubMed] [Google Scholar]; b) Paull DH, Weatherwax A, Lectka T. Tetrahedron. 2009;65:6771–6803. doi: 10.1016/j.tet.2009.05.079. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Morill LC, Smith AD. Chem Soc Rev. 2014;43:6214–6226. doi: 10.1039/c4cs00042k. [DOI] [PubMed] [Google Scholar]
- [3].a) Taylor JE, Bull SD, Williams JMJ. Chem Soc Rev. 2012;41:2109–2121. doi: 10.1039/c2cs15288f. [DOI] [PubMed] [Google Scholar]; b) Merad J, Pons J-M, Chuzel O, Bressy C. Eur J Org Chem. 2016:5589–5610. [Google Scholar]; c) Birman VB. Aldrichim Acta. 2016;49:23–33. [Google Scholar]; d) Hartley WC, Smith AD. Synthesis. 2017;49:3303–3310. [Google Scholar]; e) Biswas A, Mondal H, Maji MS. J Het Chem. 2020;57:3818–3844. [Google Scholar]; f) McLaughlin C, Smith AD. Chem Eur J. 2021;27:1533–15555. doi: 10.1002/chem.202002059. [DOI] [PMC free article] [PubMed] [Google Scholar]; g) Bitai J, Westwood MT, Smith AD. Org Biomol Chem. 2021;19:2366–2384. doi: 10.1039/d0ob02208j. [DOI] [PubMed] [Google Scholar]; h) Nimmo AJ, Young CM, Smith AD. In: Asymmetric Organocatalysis: New Strategies, Catalysts, and Opportunities. Albrecht L, Albrecht A, Dell’Amico L, editors. Wiley-VCH; 2023. Isothiourea catalysis – new opportunities for asymmetric synthesis; p. 151. [Google Scholar]
- [4].a) Fu GC. Acc Chem Res. 2000;33:412–420. doi: 10.1021/ar990077w. [DOI] [PubMed] [Google Scholar]; b) France S, Guerin DJ, Miller SJ, Lectka T. Chem Rev. 2003;103:2985–3012. doi: 10.1021/cr020061a. [DOI] [PubMed] [Google Scholar]; c) Fu GC. Acc Chem Res. 2004;37:542–547. doi: 10.1021/ar030051b. [DOI] [PubMed] [Google Scholar]; d) Candish L, Nakano Y, Lupton DW. Synthesis. 2014;46:1823–1835. [Google Scholar]
- [5].Song CE, editor. Cinchona Alkaloids in Synthesis & Catalysis. Wiley-VCH; 2009. [Google Scholar]
- [6].General reviews on carbenes in asymmetric organocatalysis: Enders D, Niemeier O, Henseler A. Chem Rev. 2007;107:5606–5655. doi: 10.1021/cr068372z. ; b) Marion N, Nolan SP. Angew Chem Int Ed. 2007;46:2988–3000. doi: 10.1002/anie.200603380. [DOI] [PubMed] [Google Scholar]
- [7].a) Paull DH, Abraham CJ, Scerba MT, Alden-Danforth E, Lectka T. Acc Chem Res. 2008;41:655–663. doi: 10.1021/ar700261a. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Knox GJ, Hutchings-Goetz LS, Pearson CM, Snaddon TN. Top Curr Chem. 2020;378:16. doi: 10.1007/s41061-020-0279-7. [DOI] [PubMed] [Google Scholar]; c) Wang PS, Chen DF, Gong L-Z. Top Curr Chem. 2020;378:9. doi: 10.1007/s41061-019-0263-2. [DOI] [PubMed] [Google Scholar]
- [8].For seminal contributions in this field:. Eder U, Sauer G, Wiechert R. Angew Chem Int Ed. 1971;10:496–497. ; b) Hajos ZG, Parrish DR. J Org Chem. 1974;39:1615. 162. [Google Scholar]; c) List B, Lerner RA, Barbas CF., III J Am Chem Soc. 2000;122:2395–2396. [Google Scholar]; d) Ahrendt KA, Borths CJ, MacMillan DWC. J Am Chem Soc. 2000;122:4243–4244. [Google Scholar]
- [9].For pioneering reports on asymmetric benzoin condensations:. Sheehan JC, Hunneman DH. J Am Chem Soc. 1966;88:3666–3667. ; b) Sheehan JC, Hara T. J Org Chem. 1974;39:1196–1199. [Google Scholar]
- [10].Pracejus H. Liebigs Ann Chem. 1960;634:9–22. [Google Scholar]
- [11].For reviews on organocatalytic α-heterofunctionalizations:. Guillena G, Ramon DJ. Tetrahedron: Asymmetry. 2006;17:1465–1492. ; b) Schörgenhumer J, Tiffner M, Waser M. Beilstein J Org Chem. 2017;13:1753–1769. doi: 10.3762/bjoc.13.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].a) Wack H, Taggi AE, Hafez AM, Drury WJ, Lectka T. J Am Chem Soc. 2001;123:1531–1532. doi: 10.1021/ja005791j. [DOI] [PubMed] [Google Scholar]; b) Hafez AM, Taggi AE, Wack H, Esterbrook J, Lectka T. Org Lett. 2001;3:2049–2051. doi: 10.1021/ol0160147. [DOI] [PubMed] [Google Scholar]
- [13].a) Reynolds NT, Rovis T. J Am Chem Soc. 2005;127:16406–16407. doi: 10.1021/ja055918a. [DOI] [PubMed] [Google Scholar]; b) Vora HU, Rovis T. J Am Chem Soc. 2010;132:2860–2861. doi: 10.1021/ja910281s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].a) Liang J, Ruble JC, Fu GC. J Org Chem. 1998;63:3154–3155. [Google Scholar]; b) Yang X, Birman VB. Adv Synth Catal. 2009;351:2301–2304. doi: 10.1002/adsc.200900451. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Yang X, Lu G, Birman VB. Org Lett. 2010;12:892–895. doi: 10.1021/ol902969j. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Yang X, Birman VB. Chem Eur J. 2011;17:11296–11304. doi: 10.1002/chem.201101028. [DOI] [PubMed] [Google Scholar]
- [15].a) Huang Y, Calter MA. Tetrahedron Lett. 2007;48:1657–1659. [Google Scholar]; b) Jiang S, Hu B, Yu X, Deng W. Chin J Chem. 2014;32:694–698. [Google Scholar]; c) Straub MR, Birman VB. Org Lett. 2018;20:7550–7553. doi: 10.1021/acs.orglett.8b03297. [DOI] [PubMed] [Google Scholar]; d) Stockhammer L, Craik R, Monkowius U, Cordes DB, Smith AD, Waser M. ChemistryEurope. 2023;1:e202300015 [Google Scholar]
- [16].a) West TH, Daniels DSB, Slawin AMZ, Smith AD. J Am Chem Soc. 2014;136:4476–4479. doi: 10.1021/ja500758n. [DOI] [PubMed] [Google Scholar]; b) Spoehrle SSM, West TH, Taylor JE, Slawin AMZ, Smith AD. J Am Chem Soc. 2017;139:11895–11902. doi: 10.1021/jacs.7b05619. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Zhang L, Zhang ZJ, Xiao JY, Song J. Org Lett. 2018;20:5519–5522. doi: 10.1021/acs.orglett.8b02521. [DOI] [PubMed] [Google Scholar]
- [17].For general reviews on asymmetric α-halogenations:. France S, Weatherwax A, Lectka T. Eur J Org Chem. 2005:475–479. ; b) Oestreich M. Angew Chem Int Ed. 2005;44:2324–2329. doi: 10.1002/anie.200500478. [DOI] [PubMed] [Google Scholar]; c) Ma J-A, Cahard D. Chem Rev. 2008;108:PR1–PR43. doi: 10.1021/cr800221v. [DOI] [PubMed] [Google Scholar]; d) Ueda M, Kanoa T, Maruoka K. Org Biomol Chem. 2009;7:2005–2012. doi: 10.1039/b901449g. [DOI] [PubMed] [Google Scholar]; e) Shibatomi K, Narayama A. Asian J Org Chem. 2013;2:812–823. [Google Scholar]; f) Liang T, Neumann CN, Ritter T. Angew Chem Int Ed. 2013;52:8214–8264. doi: 10.1002/anie.201206566. [DOI] [PubMed] [Google Scholar]; g) Yang X, Wu T, Phipps RJ, Toste FD. Chem Rev. 2015;115:826–870. doi: 10.1021/cr500277b. [DOI] [PMC free article] [PubMed] [Google Scholar]; h) Gomez-Martinez M, Alonso DA, Pastor IM, Guillena G, Baeza A. Asian J Org Chem. 2016;5:1428–1437. [Google Scholar]
- [18].a) Taggi AE, Wack H, Hafez AM, France S, Lectka T. Org Lett. 2002;4:627–629. doi: 10.1021/ol0172525. [DOI] [PubMed] [Google Scholar]; b) France S, Wack H, Taggi AE, Hafez AM, Wagerle TR, Shah MH, Dusich CL, Lectka T. J Am Chem Soc. 2004;126:4245–4255. doi: 10.1021/ja039046t. [DOI] [PubMed] [Google Scholar]; c) Bernstein D, France S, Wolfer J, Lectka T. Tetrahedron: Asymmetry. 2005;16:3481–3483. [Google Scholar]; d) Dogo-Isonagie C, Bekele T, France S, Wolfer J, Weatherwax A, Taggi AE, Lectka T. J Org Chem. 2006;71:8946–8949. doi: 10.1021/jo061522l. [DOI] [PubMed] [Google Scholar]; e) Dogo-Isonagie C, Bekele T, France S, Wolfer J, Weatherwax A, Taggi AE, Paull DH, Dudding T, Lectka T. Eur J Org Chem. 2007:1091–1100. doi: 10.1021/jo061522l. [DOI] [PubMed] [Google Scholar]
- [19].a) Lee EC, McCauley KM, Fu GC. Angew Chem Int Ed. 2007;46:977–979. doi: 10.1002/anie.200604312. [DOI] [PubMed] [Google Scholar]; b) Douglas J, Ling KB, Churchill G, Slawin AMZ, Smith AD. Eur J Org Chem. 2010:5863–5869. [Google Scholar]; c) Douglas JJ, Churchill G, Slawin AMZ, Fox DJ, Smith AD. Chem Eur J. 2015;21:16354–16358. doi: 10.1002/chem.201503308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].a) Paull DH, Scerba MT, Alden-Danforth E, Widger LR, Lectka T. J Am Chem Soc. 2008;130:17260–17261. doi: 10.1021/ja807792c. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Erb J, Alden-Danforth E, Kopf N, Scerba MT, Lectka T. J Org Chem. 2010;75:969–971. doi: 10.1021/jo9024072. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Erb J, Paull DH, Dudding T, Belding L, Lectka T. J Am Chem Soc. 2011;133:7536–7546. doi: 10.1021/ja2014345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Lee SY, Neufeind S, Fu GC. J Am Chem Soc. 2014;136:8899–8902. doi: 10.1021/ja5044209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].a) Yuan S, Liao C, Zheng WH. Org Lett. 2021;23:4142–4146. doi: 10.1021/acs.orglett.1c01046. [DOI] [PubMed] [Google Scholar]; b) Yuan S, Zheng WH. J Org Chem. 2022;87:713–720. doi: 10.1021/acs.joc.1c02710. [DOI] [PubMed] [Google Scholar]
- [23].a) Stockhammer L, Weinzierl D, Waser M. Org Lett. 2021;23:6143–6147. doi: 10.1021/acs.orglett.1c02256. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Weinzierl D, Piringer M, Zebrowski P, Stockhammer L. Mario Waser, Org Lett. 2023;25:3126–3130. doi: 10.1021/acs.orglett.3c00986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].a) Zhao Y-M, Cheung MS, Lin Z, Sun J. Angew Chem Int Ed. 2012;51:10359–10363. doi: 10.1002/anie.201204521. [DOI] [PubMed] [Google Scholar]; b) Li F, Wu Z, Wang J. Angew Chem Int Ed. 2015;54:656–659. doi: 10.1002/anie.201409473. [DOI] [PubMed] [Google Scholar]; c) Dong X, Yang W, Hu W, Sun J. Angew Chem Int Ed. 2015;54:660–663. doi: 10.1002/anie.201409961. [DOI] [PubMed] [Google Scholar]
- [25].For general reviews on asymmetric α-heterofunctionalizations:. Janey JM. Angew Chem Int Ed. 2005;44:4292–4300. doi: 10.1002/anie.200462314. ; b) Smith AMR, Hii KK. Chem Rev. 2011;111:1637–1656. doi: 10.1021/cr100197z. [DOI] [PubMed] [Google Scholar]; c) Gu X, Wang L, Gao Y-F, Ma W, Li Y-M, Gong P. Tetrahedron: Asymmetry. 2014;25:1573–1580. [Google Scholar]; d) Chauhan P, Mahajan S, Enders D. Chem Rev. 2014;114:8807–8864. doi: 10.1021/cr500235v. [DOI] [PubMed] [Google Scholar]
- [26].a) Bekele T, Shah MH, Wolfer J, Abraham CJ, Weatherwax A, Lectka T. J Am Chem Soc. 2006;128:1810–1811. doi: 10.1021/ja058077g. [DOI] [PubMed] [Google Scholar]; b) Abraham CJ, Paull DH, Bekele T, Scerba MT, Dudding T, Lectka T. J Am Chem Soc. 2008;130:17085–17094. doi: 10.1021/ja806818a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Dochnahl M, Fu GC. Angew Chem Int Ed. 2009;48:2391–2393. doi: 10.1002/anie.200805805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].For reviews on the use of oxaziridines:. Davis FA, Chen BC. Chem Rev. 1992;92:919–934. ; b) Ren Q, Yang W, Lan Y, Qin X, He Y, Yuan L. Molecules. 2018;23:2656–2672. doi: 10.3390/molecules23102656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Shao P-L, Chen X-Y, Ye S. Angew Chem Int Ed. 2010;49:8412–8416. doi: 10.1002/anie.201003532. [DOI] [PubMed] [Google Scholar]
- [30].Smith SR, Fallan C, Taylor JE, McLennan R, Daniels DSB, Morril LC, Slawin AMZ, Smith AD. Chem Eur J. 2015;21:10530–10536. doi: 10.1002/chem.201501271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Yuan Y-C, Sater MAE, Mellah M, Jaber N, David ORP, Schulz E. Org Chem Front. 2021;8:4693–4699. [Google Scholar]
- [32].a) Abraham CJ, Paull DH, Scerba MT, Grebinski JW, Lectka T. J Am Chem Soc. 2006;128:13370–13371. doi: 10.1021/ja065754d. [DOI] [PubMed] [Google Scholar]; b) Wolfer J, Bekele T, Abraham CJ, Dogo-Isonagie C, Lectka T. Angew Chem Int Ed. 2006;45:7398–7400. doi: 10.1002/anie.200602801. [DOI] [PubMed] [Google Scholar]; c) Paull DH, Alden-Danforth E, Wolfer J, Dogo-Isonagie C, Abraham CJ, Lectka T. J Org Chem. 2007;72:5380–5382. doi: 10.1021/jo070472x. [DOI] [PubMed] [Google Scholar]
- [33].Berlin JM, Fu GC. Angew Chem Int Ed. 2008;47:7048–7050. doi: 10.1002/anie.200802439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Huang X-L, He L, Shao P-L, Ye S. Angew Chem Int Ed. 2009;48:192–195. doi: 10.1002/anie.200804487. [DOI] [PubMed] [Google Scholar]
- [35].a) Morill LC, Lebl T, Slawin AMZ, Smith AD. Chem Sci. 2012;3:2088–2093. [Google Scholar]; b) Morill LC, Ledingham LA, Couturier J-P, Bickel J, Harper AD, Fallan C, Smith AD. Org Biomol Chem. 2014;12:624–636. doi: 10.1039/c3ob41869c. [DOI] [PubMed] [Google Scholar]; c) Morrill LC, Smith SM, Slawin AMZ, Smith AD. J Org Chem. 2014;79:1640–1655. doi: 10.1021/jo402591v. [DOI] [PubMed] [Google Scholar]
- [36].Song J, Zhang Z-J, Chen S-S, Fan T, Gong L-Z. J Am Chem Soc. 2018;140:3177–3180. doi: 10.1021/jacs.7b12628. [DOI] [PubMed] [Google Scholar]
- [37].Taylor JE, Daniels DSB, Smith AD. Org Lett. 2013;15:6058–6061. doi: 10.1021/ol402955f. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
This is a review article. Everything covered herein was cited in the reference section.














